Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;44(1):119-126.
doi: 10.1007/s40618-020-01278-6. Epub 2020 May 4.

Effects of glucose variability on hematopoietic stem/progenitor cells in patients with type 1 diabetes

Affiliations

Effects of glucose variability on hematopoietic stem/progenitor cells in patients with type 1 diabetes

F Boscari et al. J Endocrinol Invest. 2021 Jan.

Abstract

Background and purpose: Diabetes reduces the levels of hematopoietic stem/progenitor cells (HSPCs), which can contribute to organ and tissue homeostasis. Among patients with diabetes, lower HSPC levels predict the development or worsening of micro- and macro-angiopathy. High glucose variability is also associated with diabetic complications and we have previously shown that acute hypoglycaemia can stimulate stem/progenitor cells. Thus, we evaluated the relationship between glucose variability or time in hypoglycaemia and HSPCs in patients with type 1 diabetes (T1D).

Methods: Patients with T1D were compared to healthy subjects. HSPCs (CD34+, CD133+, CD34+CD133+, CD34 + CD45dim) were quantified by flow cytometry. Using flash glucose monitoring system for 90 days, we calculated several measures of glucose variability and time in hypoglycaemia.

Results: Forty-four patients with T1D and 44 healthy subjects were enrolled. Compared to healthy controls, T1D patients had significantly lower levels of HSPCs and duration of diabetes was inversely correlated with HSPC levels. Significant direct correlations were found between HSPC levels and the coefficient of variation of glucose levels or time in hypoglycaemia, which were stronger in patients with short-term than in those with long-standing diabetes.

Conclusion: This study confirms the pauperization of HSPCs in T1D patients and demonstrates a potential HSPC-stimulatory effect of hypoglycaemia, which mitigates with long-lasting diabetes. These data are consistent with a model whereby disease chronicity progressively blunts the release of HSPCs in response to adrenergic triggers, like hypoglycaemic events.

Keywords: Continuous glucose monitoring; Endothelial progenitor cells; Flash glucose monitoring system; Glucose variability; Hematopoietic stem/progenitor cells; Type 1 diabetes.

PubMed Disclaimer

References

    1. Rao Kondapally Seshasai S, Kaptoge S, Thompson A et al (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364:829–841. https://doi.org/10.1056/NEJMoa1008862 - DOI - PubMed - PMC
    1. Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615–1625. https://doi.org/10.2337/diabetes.54.6.1615 - DOI - PubMed
    1. Service FJ (2013) Glucose variability. Diabetes 62:1398–1404. https://doi.org/10.2337/db12-1396 - DOI - PubMed - PMC
    1. Brownlee M, Hirsch IB (2006) Glycemic variability: a hemoglobin A1c–independent risk factor for diabetic complications. JAMA 295:1707–1708. https://doi.org/10.1001/jama.295.14.1707 - DOI - PubMed
    1. Su G, Mi S, Tao H et al (2011) Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol 10:19. https://doi.org/10.1186/1475-2840-10-19 - DOI - PubMed - PMC

LinkOut - more resources